Jacobs Levy Equity Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $5.44M | Sell |
|
|||||
|
2024
Q2 | $26.1M | Sell |
|
|||||
|
2024
Q1 | $32.1M | Sell |
|
|||||
|
2023
Q4 | $34.4M | Sell |
|
|||||
|
2023
Q3 | $26.7M | Buy |
|
|||||
|
2023
Q2 | $27.9M | Sell |
|
|||||
|
2023
Q1 | $31.1M | Buy |
|
|||||
|
2022
Q4 | $30.6M | Buy |
|
|||||
|
2022
Q3 | $9.15M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $242K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $978K | Sell |
|
|||||
|
2020
Q2 | $2.1M | Buy |
|
|||||
|
2020
Q1 | $434K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $241K | Buy |
|